Comparative Efficacy and Safety of Five Anti-Calcitonin Gene-Related Peptide Agents for Migraine Prevention: A Network Meta-Analysis.

Wenfang Sun, Hua Cheng,Binbin Xia, Xianjun Liu,Yali Li,Xuemei Wang, Chengjiang Liu

The Clinical journal of pain（2023）

引用 0|浏览0

暂无评分

摘要

All anti-CGRP agents were more effective than placebo in migraine prevention. Overall, monthly fremanezumab 225 mg, monthly erenumab 140 mg, and daily atogepant 60 mg were effective interventions with fewer side effects.

查看译文

关键词

migraine, prevention, network meta-analysis, calcitonin gene-related peptide

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要